Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Image: A pipette dispensing blue liquid into a test tube

About the event

Speakers on the night will share insight on the new era of cancer prevention trials. Research and clinical trials in cancer prevention are critical for improving patient outcomes and reducing pressure on healthcare systems. The new field of precision prevention exploits biological insights into risk factors and cancer development to precisely target interventions to individuals at high risk, with the aim of delaying or preventing cancer. Oxford University hosts the UK's first and only Cancer Research UK-accredited trials centre specialising in cancer precision prevention studies and is changing the way that these trials are run. Compared to traditional cancer prevention trials, precision prevention trials are more focused, smaller and shorter, and thus more attractive to commercial timelines. This event will highlight the innovations in cancer prevention trials and explore the impact on pharma and people affected by a high-risk condition.

Date: Tuesday, 2 July 2024
Time: 17:00 - 20:00
Location: Meeting room 1/2/3, BioEscalator, University of Oxford, Innovation Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ

See the programme and register


This event has been made possible by the collaborative efforts of:


OBN logo 


Event hosts

BioEscalator logoOxford Cancer logo Medical Sciences Division Business Partnerships Office logo